ACTIVE SUBSTANCE / INN

NAPROXEN SODIUM

Brand name(s): NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE, NAPROXEN SODIUM, SUMATRIPTAN; NAPROXEN SODIUM, ALEVE PM, NAPRELAN, NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE, SUMATRIPTAN AND NAPROXEN SODIUM
FDA LISTED
PRESCRIPTION
OVER-THE-COUNTER
DISCONTINUED
ANDA207597
ANDA078314
ACTIVE SUBSTANCE
Naproxen Sodium
REGULATORS
FDA
SPONSORS / MAH
PERRIGO R AND D, SUN PHARM INDS LTD, MARKSANS PHARMA
TOTAL APPLICATIONS
10
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
NAPROXEN SODIUMANDA090545MARKSANS PHARMAOver-the-counter
NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDEANDA211360AUROBINDO PHARMAOver-the-counter
SUMATRIPTAN; NAPROXEN SODIUMANDA090930DR REDDYS LABS LTDNone (Tentative Approval)
NAPROXEN SODIUMANDA091183SUN PHARM INDS LTDDiscontinued
NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDEANDA208499PERRIGO R AND DOver-the-counter
NAPROXEN SODIUMANDA078314GLENMARK PHARMS LTDPrescription
SUMATRIPTAN AND NAPROXEN SODIUMANDA090872RISINGPrescription
ALEVE PMNDA205352BAYER HLTHCAREOver-the-counter
NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDEANDA207597P AND LDiscontinued
NAPRELANNDA020353TWI PHARMSPrescription

FULL INTELLIGENCE ON NAPROXEN SODIUM

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →